Ibio Inc (IBIO) |
|
1.38 0.01 (0.73%)
|
04-13 10:01 |
|
Open: |
1.36 |
Pre. Close: |
1.37 |
|
High:
|
1.38 |
Low:
|
1.35 |
|
Volume:
|
476,366 |
Market Cap:
|
298M |
|
|
|
|
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The firm's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The firm is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The firm's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.442 - 1.453 |
1.453 - 1.461 |
|
Low:
|
1.336 - 1.349 |
1.349 - 1.357 |
|
Close:
|
1.354 - 1.373 |
1.373 - 1.386 |
|
Technical analysis |
as of: 2021-04-12 4:54:49 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.95  One year: 2.17 |
| Support: |
Support1: 1.36 Support2: 1.13 |
| Resistance: |
Resistance1: 1.67 Resistance2: 1.86 |
| Pivot: |
1.55  |
| Moving Average: |
MA(5): 1.47 MA(20): 1.60
MA(100): 1.60 MA(250): 1.92 |
| MACD: |
MACD(12,26): -0.08 Signal(9): -0.07 |
| Stochastic oscillator: |
%K(14,3): 11.67 %D(3): 18.61 |
| RSI: |
RSI(14): 35.36 |
| 52-week: |
High: 7.45 Low: 0.86 Change(%): 45.7 |
| Average Vol(K): |
3-Month: 1272388 10-Days: 274427 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.IBIO has closed below the lower band by 3.2%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 49% narrower than normal. The narrow width of the bands suggests low volatility as compared to IBIO's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Mon, 05 Apr 2021
iBio Inc. stock underperforms Monday when compared to competitors - MarketWatch
Thu, 01 Apr 2021
iBio Inc. stock outperforms competitors on strong trading day - MarketWatch
Wed, 31 Mar 2021
iBio Inc. stock outperforms market on strong trading day - MarketWatch
Tue, 30 Mar 2021
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
Fri, 26 Mar 2021
iBio Inc. stock remains steady Friday, underperforms market - MarketWatch
Thu, 25 Mar 2021
What is Wall Street's Target Price for Ibio Inc (IBIO) Stock Thursday? - InvestorsObserver
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
174 |
| Shares Float (M) |
117 |
|
% Held by Insiders
|
8.78 |
|
% Held by Institutions
|
11.56 |
|
Shares Short (K)
|
20,000 |
|
Shares Short P. Month (K)
|
7,300 |
Stock Financials |
|
EPS
|
-0.975 |
|
EPS Est This Year
|
-0.150 |
|
EPS Est Next Year
|
-0.200 |
|
Book Value (p.s.)
|
0.040 |
|
Profit Margin
|
|
|
Operating Margin
|
-1138.46 |
|
Return on Assets (ttm)
|
-24.0 |
|
Return on Equity (ttm)
|
-320.6 |
|
Qtrly Rev. Growth
|
-81.8 |
|
Gross Profit (p.s.)
|
0.012 |
|
Sales Per Share
|
0.008 |
|
EBITDA (p.s.)
|
-0.074 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-1.41 |
|
PEG Ratio
|
|
|
Price to Book value
|
34.25 |
|
Price to Sales
|
182.41 |
|
Price to Cash Flow
|
-17.23 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
